| Item | Cat. No. | Application | Isotype |
| Anti-HLA class I mAbs [F17B1](MABL-1846) | MABL-1846 | FACS, in vivo, FC | Engineer antibody |
| Anti-HLA Class I mAbs [SIE 4A4](MABL-1847) | MABL-1847 | Engineer antibody | |
| Anti-HLA class II mAbs [F3.3](MABL-1848) | MABL-1848 | WB, FC | Engineer antibody |
| Anti-HLA ClassII DQ mAbs [SPV-L3](MABL-1849) | MABL-1849 | Engineer antibody | |
| Anti-HLA-A1:MAGE-A1 complex mAbs [HYB3](MABL-1850) | MABL-1850 | functional assay, ELISA, FC | Engineer antibody |
| Anti-HLA-A2 mAbs [BB7.2](MABL-1851) | MABL-1851 | WB, ELISA, FC, IF, IHC | Engineer antibody |
| Anti-HLA-A2 mAbs [MBW1](MABL-1852) | MABL-1852 | functional assay, ELISA | Engineer antibody |
| Anti-HLA-A2 mAbs [SN66E3](MABL-1853) | MABL-1853 | FC; | Engineer antibody |
| Anti-HLA-A2 mAbs [UL-5 A1](MABL-1854) | MABL-1854 | FC | Engineer antibody |
| Anti-HLA-A2/A28 mAbs [3PF12](MABL-1855) | MABL-1855 | FC, IF | Engineer antibody |
| Anti-HLA-class I mAbs [YTH 862.2](MABL-1856) | MABL-1856 | IP, FC, IF | Engineer antibody |
| Anti-HLA-Cw6 mAbs [Cw6_4](MABL-1857) | MABL-1857 | IP, FC | Engineer antibody |
| Anti-HLA-DR mAbs [1D10 (Hu1D10; Apolizumab)](MABL-1858) | MABL-1858 | IP, therapeutic, FC | Engineer antibody |
| Anti-HLA-DR mAbs [BAG 14D6](MABL-1859) | MABL-1859 | Engineer antibody | |
| Anti-HLA-DR mAbs [CAT 13.3H3](MABL-1860) | MABL-1860 | Engineer antibody | |
| Anti-HLA-DR mAbs [clone I-2](MABL-1861) | MABL-1861 | ELISA | Engineer antibody |
| Anti-HLA-DR mAbs [HD8](MABL-1862) | MABL-1862 | immunotherapy, WB, FC | Engineer antibody |
| Anti-HLA-DR mAbs [L243](MABL-1863) | MABL-1863 | ICC, in vivo, IP, WB, Block, ELISA, FC, IF, IHC | Engineer antibody |
| Anti-HLA-DR10 mAbs [Lym-1](MABL-1864) | MABL-1864 | Immunoperoxidase staining, IP, RIA, WB, FC, IF, IHC | Engineer antibody |
| Anti-HLA-E mAbs [3D12](MABL-1865) | MABL-1865 | functional assay, FC, IF | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
